Search Results - Al-Sallami, H.

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    Long term use of tamoxifen

    Long term use of tamoxifen by Al-Salami, Hani, Al-Sallami, H., Van Zyl, Ingrid

    Published 2012
    Get full text
  2. 2
    The biological effects of the hypolipidaemic drug probucol microcapsules fed daily for 4 weeks, to an insulin-resistant mouse model: potential hypoglycaemic and anti-inflammatory effects

    The biological effects of the hypolipidaemic drug probucol microcapsules fed daily for 4 weeks, to an insulin-resistant mouse model: potential hypoglycaemic and anti-inflammatory e... by Mooranian, Armin, Negrulj, Rebecca, Takechi, Ryu, Mamo, John, Al-Sallami, H., Al-Salami, Hani

    Published 2018
    Get full text
  3. 3
    Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment (vol 32, pg 151, 2014)

    Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment (vol 32, pg 151, 2014) by Mooranian, A., Negrulj, R., Al-Sallami, H., Fang, Z., Mikov, M., Golocorbin-Kon, S., Fakhoury, M., Arfuso, Frank, Al-Salami, S.

    Published 2015
    Get full text
  4. 4
    Pharmacological effects of nanoencapsulation of human-based dosing of probucol on ratio of secondary to primary bile acids in gut, during induction and progression of type 1 diabetes

    Pharmacological effects of nanoencapsulation of human-based dosing of probucol on ratio of secondary to primary bile acids in gut, during induction and progression of type 1 diabet... by Mooranian, Armin, Zamani, Nassim, Takechi, Ryu, Al-Sallami, H., Mikov, M., Golocorbin-Kon, S., Kovacevic, B., Arfuso, Frank, Al-Salami, Hani

    Published 2018
    Get full text
  5. 5
    Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment

    Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment by Mooranian, Armin, Negrulj, Rebecca, Al-Sallami, H., Fang, Zhongxiang, Mikov, M., Golocorbin-Kon, S., Fakhoury, M., Arfuso, Frank, Al-Salami, Hani

    Published 2015
    Get full text
  6. 6
    Swelling, mechanical strength, and release properties of probucol microcapsules with and without a bile acid, and their potential oral delivery in diabetes

    Swelling, mechanical strength, and release properties of probucol microcapsules with and without a bile acid, and their potential oral delivery in diabetes by Negrulj, R., Mooranian, A., Chen-Tan, N., Al-Sallami, H., Mikov, M., Golocorbin-Kon, S., Fakhoury, M., Watts, G., Arfuso, Frank, Al-Salami, H.

    Published 2015
    Get full text
  7. 7
    Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: A Characterization Study

    Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: A Characterization Study by Mooranian, Armin, Negrulj, Rebecca, Chen-Tan, Nigel, Al-Sallami, H., Fang, Zhongxiang, Mukkur, Trilochan, Mikov, Momir, Golocorbin-Kon, S., Fakhoury, M., Arfuso, Frank, Al-Salami, Hani

    Published 2014
    Get full text
  8. 8
    Mammary Gland Pathology Subsequent to Acute Infection with Strong versus Weak Biofilm Forming Staphylococcus aureus Bovine Mastitis Isolates: A Pilot Study Using Non-Invasive Mouse Mastitis Model

    Mammary Gland Pathology Subsequent to Acute Infection with Strong versus Weak Biofilm Forming Staphylococcus aureus Bovine Mastitis Isolates: A Pilot Study Using Non-Invasive Mouse... by Gogoi Tiwari, Jully, Williams, Vincent, Waryah, Charlene, Costantino, Paul, Al-Salami, Hani, Mathavan, Sangeetha, Wells, Kelsi, Tiwari, H., Hegde, N., Isloor, S., Al-Sallami, H., Mukkur, Trilochan

    Published 2017
    Get full text
  9. 9
    Probucol Release from Novel Multicompartmental Microcapsules for the Oral Targeted Delivery in Type 2 Diabetes

    Probucol Release from Novel Multicompartmental Microcapsules for the Oral Targeted Delivery in Type 2 Diabetes by Mooranian, Armin, Negrulj, Rebecca, Al-Sallami, H., Fang, Zhongxiang, Mikov, Momir, Golocorbin-Kon, S., Fakhoury, M., Watts, G., Matthews, V., Arfuso, Frank, Lambros, Amanda, Al-Salami, Hani

    Published 2014
    Get full text
  10. 10
    Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol

    Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol by Mooranian, Armin, Negrulj, Rebecca, Chen-Tan, Nigel, Al-Sallami, H., Fang, Zhongxiang, Mukkur, Trilochan, Mikov, M., Golocorbin-Kon, S., Fakhoury, M., Watts, G., Matthews, V., Arfuso, Frank, Al-Salami, Hani

    Published 2014
    Get full text

Search Tools: